Home > Healthcare > Medical Devices > Medical Supplies > Nasal Cannula Market

Nasal Cannula Market Size

Report ID: GMI4548
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Nasal Cannula Market Size

Nasal Cannula Market was valued at USD 7.5 billion in 2022 and is poised to grow at a CAGR of over 6.2% from 2023 to 2032. A nasal cannula is a medical device used to deliver supplemental oxygen to individuals that require increased oxygen levels in their bloodstream. It is a lightweight, flexible tube that typically consists of two prongs that are inserted into the nostrils. The other end of the tube is connected to an oxygen source, such as an oxygen cylinders and concentrators.

To get key market trends

Download Free Sample

According to the American Hospital Association, over 34 million patients were admitted to U.S. hospitals for both critical and non-critical procedures in 2022. Consequently, the high rate of hospital admissions is said to drive market growth of cannula throughout the forecast period.

The overall healthcare landscape has witnessed a notable surge in surgical procedures necessitating oxygen support in recent years. There has been a significant increase in the number of surgeries wherein patients require supplemental oxygen. This rise is attributed to several factors, including an aging population base with a higher prevalence of respiratory issues, an increase in complex surgical interventions, and the expanding scope of elective procedures.

Nasal Cannula Market Report Attributes
Report Attribute	Details
Base Year:	2022
Nasal Cannula Market Size in 2022:	USD 7.5 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	6.2%
2032 Value Projection:	USD 13.5 Billion
Historical Data for:	2018 to 2022
No. of Pages:	150
Segments covered:	Type, Material, Application, End-use, and Region
Growth Drivers:	Increasing prevalence of respiratory disorders Advancements in technology and design Increasing home healthcare adoption Rise in surgical procedures requiring oxygen support
Pitfalls & Challenges:	Availability of alternative respiratory devices Compliance issue with infection prevention

Learn more about the key segments shaping this market

Download Free Sample

The demand for oxygen support during surgeries underscores the critical importance of ensuring optimal oxygenation for patients undergoing various medical interventions. This trend emphasizes the need for healthcare facilities to adapt and enhance their infrastructure and resources to meet the growing requirements of oxygen-dependent surgical procedures.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Nasal cannula industry was worth USD 7.5 billion in revenue in 2022 and is projected to reach USD 13.5 billion by 2032 driven by the aging population base with higher prevalence of respiratory issues and the increase in complex surgical interventions.

Low flow segment garnered USD 5.4 billion in revenue in 2022 and is estimated to witness high demand through 2032 attributed to widespread usage in chronic conditions, such as chronic obstructive pulmonary disease (COPD) and sleep apnea.

U.S. nasal cannula market size exceeded USD 2.9 billion in 2022 and is poised to exhibit robust growth rate through 2032 owing to the rising changes in healthcare policies, reimbursement structures, and insurance coverage.

Some of the top nasal cannula companies are Salter Labs, Teleflex Incorporated, Becton, Dickinson and Company, Westmed, Inc., Flexicare Medical Limited, Smiths Medical, Medtronic PLC, Sorin Group, and Masimo Corporation.